Home - Chinese Journal of Cancer Research

2019 Impact Factor of CJCR: 4.135
Journal Citation Reports®, Clarivate Analytics

Cancer burden and trends in China: A review and comparison with Japan and South Korea

Cancer is the leading cause of death worldwide. Distinct geographic disparities exist in cancer burden across the world. China, Japan, and South Korea are all located in East Asia. As neighboring countries, Japan and South Korea share similar genetic backgrounds and similar culture with China. Also, in terms of cancer burden, these three countries are all facing a heavy burden of upper digestive tract cancers. This article provides an overview of cancer burden and trends in China by comparing with Japan and South Korea. Comparison among these three countries for the cancer burden and trends could be useful to track the effectiveness of national screening programs and to identify modifiable risk factors. The results can serve as a scientific reference for cancer control policy planning.

重磅来袭——中国国家卫生健康委员会肿瘤诊疗规范英文版！！！（2018年版）

为了适应我国肿瘤领域面临的发展新形势，向国际展示我国肿瘤诊疗的规范化和精准化，推动国内外肿瘤学领域的学术交流，《中国癌症研究》英文杂志(Chinese Journal of Cancer Research，CJCR)组织我国肿瘤领域知名专家学者对国家卫生健康委员会（National Health Commission of the People’s Republic of China, NHCPRC）修订的肿瘤诊疗规范（2018年版）进行编译并出版，以促进我国肿瘤临床研究成果与诊疗经验的国际传播与交流。我们希望通过对肿瘤诊疗规范的编译能够更好地推动全国临床肿瘤学科的规范化建设，帮助各级医务人员提高诊治和研究水平，同时能将更多国际水准、中国特色的研究成果和治疗意见推向国际，造福更多的肿瘤患者。

Cancer incidence and mortality in China, 2014

In 2017, National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based cancer registry data in 2014 collected from all available cancer registries. There are 449 cancer registries submitted cancer registry data in 2014, among which 339 registries’ data met the criteria of quality control and were included in analysis. These cancer registries covered 288,243,347 population, accounting for about 21.07% of the national population in 2014. Numbers of nationwide new cancer cases and deaths were estimated using calculated incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer type. The world Segi’s population was applied for age-standardized rates. Heavy cancer burden and its disparities between area, sex and age group pose a major challenge to public health in China. Nationwide cancer registry plays a crucial role in cancer prevention and control.

Cancer incidence in Beijing, 2014

To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014. A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi’s population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was 341.92/100,000 (343.50/100,000 in males, 340.33/100,000 in females). Cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.

‹ ›

Vol 32, No 3 (June 2020)

NHCPRC Guidelines

National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)

National Health Commission of the People’s Republic of China

Pages: 415-445 HTML

Editorial

Comments on Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English edition)

Zhaode Bu, Jiafu Ji

Pages: 446-447 HTML

Review Article

Integration of stereotactic radiosurgery or whole brain radiation therapy with immunotherapy for treatment of brain metastases

Zhou Su, Lin Zhou, Jianxin Xue, You Lu

Pages: 448-466 HTML

Original Article

Lead-time bias in esophageal cancer screening in high-risk areas in China

Zhao Yang, Irene OL Wong, Wei Deng, Ru Chen, Jiachen Zhou, Wenqiang Wei

Pages: 467-475 HTML

Validity of distress thermometer for screening of anxiety and depression in family caregivers of Chinese breast cancer patients receiving postoperative chemotherapy

Min Yang, Fei Ma, Bo Lan, Jianqiang Cai, Xiaoying Sun, Binghe Xu

Pages: 476-484 HTML

Dose-dense paclitaxel plus carboplatin vs. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer

Qing Li, Jiani Wang, Yuxin Mu, Tongtong Zhang, Ying Han, Jiayu Wang, Qiao Li, Yang Luo, Fei Ma, Ying Fan, Pin Zhang, Binghe Xu

Pages: 485-496 HTML

Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis

Zhongyin Yang, Chen Li, Wentao Liu, Yanan Zheng, Zhenglun Zhu, Zichen Hua, Zhentian Ni, Sheng Lu, Min Yan, Chao Yan, Zhenggang Zhu

Pages: 497-507 HTML

Characteristics of cancer susceptibility genes mutations in 282 patients with gastric adenocarcinoma

Ke Ji, Sheng Ao, Liu He, Lijiao Zhang, Li Feng, Guoqing Lyu

Pages: 508-515 HTML

No expenditure difference among patients with liver cancer at stage I−IV: Findings from a multicenter cross-sectional study in China

Haike Lei, Lin Lei, Jufang Shi, Yongzhong Wu, Ling Liang, Huiyao Huang, Mei He, Fangzhou Bai, Maomao Cao, Hui Qiu, Yuting Wang, Chengcheng Liu, Jia Du, Hong Wang, Yan Zhang, Mengdi Cao, Ji Peng, Ni Li, Chunfeng Qu, Min Dai, Wanqing Chen, Jie He

Pages: 516-529 HTML

Virtual bronchoscopic navigation without fluoroscopy guidance for peripheral pulmonary lesions in inexperienced pulmonologist

Shijie Li, Wanpu Yan, Mailin Chen, Zhongwu Li, Yanli Zhu, Qi Wu

Pages: 530-539 HTML

Protocol

A study protocol of population-based cancer screening cohort study on esophageal, stomach and liver cancer in rural China

Jiang Li, He Li, Hongmei Zeng, Rongshou Zheng, Maomao Cao, Dianqin Sun, Jiansong Ren, Wanqing Chen, Jie He

Pages: 540-546 HTML

Original Article

Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model

Maomao Cao, He Li, Dianqin Sun, Lin Lei, Jiansong Ren, Jufang Shi, Ni Li, Ji Peng, Wanqing Chen

HTML

Effects of insurance status on long-term survival among non-small cell lung cancer (NSCLC) patients in Beijing, China: A population-based study

Zheng Wang, Lei Yang, Shuo Liu, Huichao Li, Xi Zhang, Ning Wang, Jiafu Ji

HTML

NHCPRC Guidelines

National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version)

National Health Commission of the People’s Republic of China

Pages: 415-445 HTML

Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 707-737 HTML

Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 578-585 HTML

Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 557-577 HTML

Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 223-258 HTML

Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 259-277 HTML

Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 278-294 HTML

Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 295-305 HTML

Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 1-28 HTML

Chinese guidelines for diagnosis and treatment of renal cell carcinoma 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 29-48 HTML

Chinese guidelines for diagnosis and treatment of urothelial carcinoma of bladder 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 49-66 HTML

Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)

National Health Commission of the People’s Republic of China

Pages: 67-83 HTML

CSCO Guidelines

Updates in version 2020 of CSCO guidelines for colorectal cancer from version 2019

Shanshan Weng, Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 403-407 HTML

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

Pages: 423-425 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer working group

Pages: 84-98 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer working group

Pages: 99-116 HTML

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer working group

Pages: 117-134 HTML

Guidelines

Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor

Jian Li, Yingjiang Ye, Jian Wang, Bo Zhang, Shukui Qin, Yingqiang Shi, Yulong He, Xiaobo Liang, Xiufeng Liu, Ye Zhou, Xin Wu, Xinhua Zhang, Ming Wang, Zhidong Gao, Tianlong Lin, Hui Cao, Lin Shen, Chinese Society of Clinical Oncology (CSCO) Expert Committee on Gastrointestinal Stromal Tumor

2019 Impact Factor of CJCR: 4.135Journal Citation Reports®, Clarivate Analytics

Cancer burden and trends in China: A review and comparison with Japan and South Korea

重磅来袭——中国国家卫生健康委员会肿瘤诊疗规范英文版！！！（2018年版）

Cancer incidence and mortality in China, 2014

Cancer incidence in Beijing, 2014

About cjcr

Advertising

Contact us

NHCPRC Guidelines

Editorial

Review Article

Original Article

Protocol

Original Article

NHCPRC Guidelines

CSCO Guidelines

Guidelines

Virtual Special Issues

Beijing Cancer Hospital

China Anti-cancer Association

Chronic Diseases and Translational Medicine

2018 CGCC

2019 Impact Factor of CJCR: 4.135
Journal Citation Reports®, Clarivate Analytics